UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Elektrochemische Analytik

2013

Volltextzugriff (PDF)

Anti–Escherichia coli asparaginase antibody levels determine the activity of second-line treatment with pegylated E coli asparaginase: a retrospective analysis within the ALL-BFM trials

Blood, 2011-11, Vol.118 (22), p.5774-5782

2011

Volltextzugriff (PDF)

B-cell precursor leukemias with MYC -rearrangement come into the limelight

Haematologica (Roma), 2023-03, Vol.108 (3), p.659-660

2023

Volltextzugriff (PDF)

Unrelated donor stem cell transplantation compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission: a matched-pair analysis

Blood, 2003-05, Vol.101 (10), p.3835-3839

2003

Volltextzugriff (PDF)

Prognostic Value of Minimal Residual Disease Quantification Before Allogeneic Stem-Cell Transplantation in Relapsed Childhood Acute Lymphoblastic Leukemia: The ALL-REZ BFM Study Group

Journal of clinical oncology, 2009-01, Vol.27 (3), p.377-384

2009

Volltextzugriff (PDF)

Long-Term Outcome in Children With Relapsed Acute Lymphoblastic Leukemia After Time-Point and Site-of-Relapse Stratification and Intensified Short-Course Multidrug Chemotherapy: Results of Trial ALL-REZ BFM 90

Journal of clinical oncology, 2010-05, Vol.28 (14), p.2339-2347

2010

Volltextzugriff (PDF)

XIAP expression is post-transcriptionally upregulated in childhood ALL and is associated with glucocorticoid response in T-cell ALL

Pediatric blood & cancer, 2010-08, Vol.55 (2), p.260-266

2010

Volltextzugriff (PDF)

Use of Allogeneic Hematopoietic Stem-Cell Transplantation Based on Minimal Residual Disease Response Improves Outcomes for Children With Relapsed Acute Lymphoblastic Leukemia in the Intermediate-Risk Group

Journal of clinical oncology, 2013-07, Vol.31 (21), p.2736-2742

2013

Volltextzugriff (PDF)

Induction of apoptosis by enediyne antibiotic calicheamicin ϑII proceeds through a caspase-mediated mitochondrial amplification loop in an entirely Bax-dependent manner

Oncogene, 2003-12, Vol.22 (57), p.9107-9120

2003

Volltextzugriff (PDF)

Positron Emission Tomography for Staging of Pediatric Sarcoma Patients: Results of a Prospective Multicenter Trial

Journal of clinical oncology, 2007-12, Vol.25 (34), p.5435-5441

2007

Volltextzugriff (PDF)

Mutations and Deletions of the TP53 Gene Predict Nonresponse to Treatment and Poor Outcome in First Relapse of Childhood Acute Lymphoblastic Leukemia

Journal of clinical oncology, 2011-08, Vol.29 (23), p.3185-3193

2011

Volltextzugriff (PDF)

Poor Outcome for Children and Adolescents With Progressive Disease or Relapse of Lymphoblastic Lymphoma: A Report From the Berlin-Frankfurt-Muenster Group

Journal of clinical oncology, 2009-07, Vol.27 (20), p.3363-3369

2009

Volltextzugriff (PDF)

Minimal residual disease analysis by eight-color flow cytometry in relapsed childhood acute lymphoblastic leukemia

Haematologica (Roma), 2015-07, Vol.100 (7), p.935-944

2015

Volltextzugriff (PDF)

Mutations in the Nijmegen Breakage Syndrome gene (NBS1) in childhood acute lymphoblastic leukemia (ALL)

Cancer research (Baltimore), 2001-05, Vol.61 (9), p.3570-3572

2001

Volltextzugriff (PDF)

Polarographie und Voltammetrie: Grundlagen und Analytische Praxis

Henze, Günter

1, 2001

Volltextzugriff (PDF)

Early and Late Therapy Response Assessment With [18F]Fluorodeoxyglucose Positron Emission Tomography in Pediatric Hodgkin's Lymphoma: Analysis of a Prospective Multicenter Trial

Journal of clinical oncology, 2009-09, Vol.27 (26), p.4385-4391

2009

Volltextzugriff (PDF)

Autologous purified peripheral blood stem cell transplantation compare to chemotherapy in childhood acute lymphoblastic leukemia after low-risk relapse

Pediatric blood & cancer, 2011-10, Vol.57 (4), p.654-659

2011

Volltextzugriff (PDF)

Siblings of children with cancer—the price they pay to function

Supportive care in cancer, 2015-07, Vol.23 (7), p.1837-1839

2015

Volltextzugriff (PDF)

X‐linked inhibitor of apoptosis protein represents a promising therapeutic target for relapsed/refractory ALL

EMBO molecular medicine, 2023-01, Vol.15 (1), p.e14557-n/a

2023

Volltextzugriff (PDF)

Copy number genome alterations are associated with treatment response and outcome in relapsed childhood ETV6/RUNX1-positive acute lymphoblastic leukemia

Haematologica (Roma), 2014-04, Vol.99 (4), p.706-714

2014

Volltextzugriff (PDF)

Ethik im Gesundheitssystem: Steuerungsmechanismus für die Medizin der Zukunft

1st ed., 2013

Volltextzugriff (PDF)

Integrative medicine during the intensive phase of chemotherapy in pediatric oncology in Germany: a randomized controlled trial with 5-year follow up

BMC cancer, 2022-06, Vol.22 (1), p.652-652, Article 652

2022

Volltextzugriff (PDF)

1 – 25 von 318

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(236)
Mit Volltextzugriff
(277)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(248)
Deutsch
(74)
Japanisch
(28)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(168)
Life Sciences & Biomedicine
(141)
Humans
(132)
Child
(95)
Female
(79)
Male
(78)
Oncology
(76)
Biological And Medical Sciences
(75)
Medical Sciences
(72)
Adolescent
(68)
Child, Preschool
(63)
Hematology
(59)
Infant
(46)
Hematologic And Hematopoietic Diseases
(43)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(39)
Recurrence
(38)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(33)
Precursor Cell Lymphoblastic Leukemia-Lymphoma - Drug Therapy
(32)
Pediatrics
(29)
Prognosis
(29)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Elektrochemische Analytik

Anti–Escherichia coli asparaginase antibody levels determine the activity of second-line treatment with pegylated E coli asparaginase: a retrospective analysis within the ALL-BFM trials

B-cell precursor leukemias with MYC -rearrangement come into the limelight

Unrelated donor stem cell transplantation compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission: a matched-pair analysis

Prognostic Value of Minimal Residual Disease Quantification Before Allogeneic Stem-Cell Transplantation in Relapsed Childhood Acute Lymphoblastic Leukemia: The ALL-REZ BFM Study Group

THROMBOTECT - a randomized study comparing low molecular weight heparin, antithrombin and unfractionated heparin for thromboprophylaxis during induction therapy of acute lymphoblastic leukemia in children and adolescents

Long-Term Outcome in Children With Relapsed Acute Lymphoblastic Leukemia After Time-Point and Site-of-Relapse Stratification and Intensified Short-Course Multidrug Chemotherapy: Results of Trial ALL-REZ BFM 90

XIAP expression is post-transcriptionally upregulated in childhood ALL and is associated with glucocorticoid response in T-cell ALL

Use of Allogeneic Hematopoietic Stem-Cell Transplantation Based on Minimal Residual Disease Response Improves Outcomes for Children With Relapsed Acute Lymphoblastic Leukemia in the Intermediate-Risk Group

Induction of apoptosis by enediyne antibiotic calicheamicin ϑII proceeds through a caspase-mediated mitochondrial amplification loop in an entirely Bax-dependent manner

Positron Emission Tomography for Staging of Pediatric Sarcoma Patients: Results of a Prospective Multicenter Trial

A Single Dose of PEG-Asparaginase at the Beginning of Induction Not Only Accelerates MRD Clearance but Also Improves Long-Term Outcome in Children with B-Lineage ALL

Mutations and Deletions of the TP53 Gene Predict Nonresponse to Treatment and Poor Outcome in First Relapse of Childhood Acute Lymphoblastic Leukemia

Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95

Poor Outcome for Children and Adolescents With Progressive Disease or Relapse of Lymphoblastic Lymphoma: A Report From the Berlin-Frankfurt-Muenster Group

Minimal residual disease analysis by eight-color flow cytometry in relapsed childhood acute lymphoblastic leukemia

Mutations in the Nijmegen Breakage Syndrome gene (NBS1) in childhood acute lymphoblastic leukemia (ALL)

Polarographie und Voltammetrie: Grundlagen und Analytische Praxis

Early and Late Therapy Response Assessment With [18F]Fluorodeoxyglucose Positron Emission Tomography in Pediatric Hodgkin's Lymphoma: Analysis of a Prospective Multicenter Trial

Autologous purified peripheral blood stem cell transplantation compare to chemotherapy in childhood acute lymphoblastic leukemia after low-risk relapse

Siblings of children with cancer—the price they pay to function

X‐linked inhibitor of apoptosis protein represents a promising therapeutic target for relapsed/refractory ALL

Copy number genome alterations are associated with treatment response and outcome in relapsed childhood ETV6/RUNX1-positive acute lymphoblastic leukemia

Ethik im Gesundheitssystem: Steuerungsmechanismus für die Medizin der Zukunft

Integrative medicine during the intensive phase of chemotherapy in pediatric oncology in Germany: a randomized controlled trial with 5-year follow up

Suchergebnisse filtern